Peripheral blood gene expression predicts clinical benefit from anti-IL-13 in asthma

J Allergy Clin Immunol. 2016 Oct;138(4):1230-1233.e8. doi: 10.1016/j.jaci.2016.06.008. Epub 2016 Jun 29.
No abstract available

Publication types

  • Letter

MeSH terms

  • 3-Hydroxysteroid Dehydrogenases / genetics
  • Adolescent
  • Adult
  • Aged
  • Antigens, CD / genetics
  • Antigens, Differentiation, B-Lymphocyte / genetics
  • Asthma / genetics*
  • Asthma / immunology
  • Asthma / therapy*
  • Calcium Channels / genetics
  • Cell Adhesion Molecules / blood
  • Chemokines, CC / genetics
  • Child
  • Eosinophils / immunology
  • Female
  • Gene Expression
  • Genetic Markers
  • Humans
  • Interleukin-13 / antagonists & inhibitors*
  • Lectins / genetics
  • Leukocyte Count
  • Male
  • Middle Aged
  • Young Adult

Substances

  • Antigens, CD
  • Antigens, Differentiation, B-Lymphocyte
  • CACNG6 protein, human
  • CCL23 protein, human
  • Calcium Channels
  • Cell Adhesion Molecules
  • Chemokines, CC
  • Genetic Markers
  • IL13 protein, human
  • Interleukin-13
  • Lectins
  • POSTN protein, human
  • SIGLEC8 protein, human
  • 3-Hydroxysteroid Dehydrogenases